10 – Effect of Recently Described Adverse Events Related to Use of PPIS, Including Renal Disease, on Reports to the United States Food and Drug Administration
2020 ◽
Vol 312
(8)
◽
pp. 581-586
◽
Keyword(s):
2020 ◽
Vol 6
(4)
◽
pp. 272-276
2007 ◽
Vol 2007
◽
pp. 25-26
◽
2020 ◽
Vol 108
(3)
◽
pp. e203-e204
Keyword(s):
2020 ◽
Vol 95
(8)
◽
pp. 1594-1603
◽
Keyword(s):
2006 ◽
Vol 88
(3)
◽
pp. 503
◽